Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Neurogen is a Biotechnology Research brand in Melbourne. Privately held, at neurogenglobal.com. It holds one address on record, all in Australia. It employs 1 person, on the record. It is listed alongside eight similar brands, mostly in Medical Equipment Manufacturing.
Neurogen develops advanced biological brain implants to repair and restore degeneration in the cortex caused by neurological diseases.
Neurogen, as a biotech start-up, aims to address the severe socioeconomic impact caused by neurological diseases and subsequent lifetime disabilities across the globe.
Neurogen envisions a future with hope for patients of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, and expanding to other cortical lesions caused by stroke and neurodevelopmental disorders (Autism).
Our aim is to build a future where brain diseases are no longer a concern and bring hope to people's lives, “because everyone deserves a healthy brain”.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Australia only. Primary: Melbourne.
None linked to this brand.
9 profiles list Neurogen as a peer — 79th percentile in Biotechnology Research. It lists ten peers of its own. Chyral and Turquoise Biotechnologies list it back.